Clinical Trial Update: A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer [Phase 1]

View source ↗

Summary

Phase I study evaluating safety of S-1 with radiotherapy in locally advanced or recurrent gastric cancer; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastrointestinal Neoplasms, Gastric Cancer | Phase 1 | Status: COMPLETED